1. Home
  2. CNSP vs SOBR Comparison

CNSP vs SOBR Comparison

Compare CNSP & SOBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

HOLD

Current Price

$2.98

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Logo SOBR Safe Inc.

SOBR

SOBR Safe Inc.

HOLD

Current Price

$0.75

Market Cap

3.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNSP
SOBR
Founded
2017
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Newspapers/Magazines
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
3.3M
IPO Year
2019
2008

Fundamental Metrics

Financial Performance
Metric
CNSP
SOBR
Price
$2.98
$0.75
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
19.3K
181.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
72.19
EPS
N/A
N/A
Revenue
N/A
$212,736.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
35.25
52 Week Low
$0.73
$0.40
52 Week High
$10.59
$7.70

Technical Indicators

Market Signals
Indicator
CNSP
SOBR
Relative Strength Index (RSI) 20.29 28.13
Support Level $0.86 N/A
Resistance Level $9.01 $2.19
Average True Range (ATR) 0.35 0.07
MACD -0.06 0.02
Stochastic Oscillator 2.86 21.64

Price Performance

Historical Comparison
CNSP
SOBR

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

About SOBR SOBR Safe Inc.

Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.

Share on Social Networks: